مقاله اصلی ارزیابی خطر ابتلا به کمبود مواد معدنی استخوان در زنان مبتلا به لوپوس اریتماتیک سیستمیک

Bisphosphonate treatment eliminated the negative relationships between disease duration and the BMD of the spine and hip. AP spine and hip BMD in patients with SLE depend on BMI, regardless of bisphosphonate use. SLE serologic markers and glucocorticoid use were not negatively associated with generalized bone loss. SLE patients with low BMI have a high risk of generalized bone loss, and should be assessed and treated to prevent osteoporosis even before menopause.